
In vivo evaluation of the compounds isolated from microbial metabolites or synthesized in the laboratory.

1. Toxicity and PK/PD studies
- ①Acute toxicity
-
- Weight changes
- External changes
- Anatomy findings
- ②Pharmacokinetic examination
-
2. Antitumor studies
- ①Antitumor examination
-
- Human transplantable tumor
-
- Lung : LX-1, DMS-273
- Pancreatic : Capan-1, PANC-1
- Colon : DLD-1
- Prostate : LNCaP, PC-3, DU-145
- Breast : BSY-1
- Melanoma : LOX
- Others
-

DMS-273 : Small cell lung carcinoma
view |

Human pancreatic carcinoma
view |
-
- Mouse transplantable tumor
-
- Ehrlich carcinoma
- IMC carcinoma
- Sarcoma : S180
- Fibro sarcoma : Meth-A
- Leukemia : L1210, EL4
- Colon cancer : Colon26
- Melanoma : B16-F10, B16-BL6
- Others
- ②Antiangiogenic examination
-

view
- ③Antimetastatic examination
-

view
3. Antibacteria study
Model of the systemic infection caused by Staphylococcus aureus Smith.

view
4. Antiarthritic study
To induce arthritis, type II collagen emulsified with complete Freund’s adjuvant (CFA) is inoculated into the mouse on days 0 and 21. Footpad volumes and joint changes in the limbs are measured.
The experiment is performed in accordance with the Guidelines for Animal Experiments in the MCRF.